Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dynamin 1 pseudogene 38 (DNM1P38) is a human pseudogene most commonly referred to as "dynamin 1 pseudogene 38." It is also known by several aliases including DNM1DN10-2, DNM1DN11-8, DNM1DN10@, DNM1DN11@, and DNM1P42[3][6]. Pseudogenes are typically non-functional segments of DNA that resemble functional genes but cannot encode a protein. There is currently no evidence that DNM1P38 has a biological function, disease association, or any role as a therapeutic target. There are no drugs, mechanisms of action, biomarkers, or relevant safety concerns associated with this locus. The term "dynamin 1 pseudogene 38" specifically indicates it is a genomic relic of the DNM1 gene and not an active gene product[3][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dynamin 1 pseudogene 38 (DNM1P38).